| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 7,7 k € | -91.1% | 86,0 k € | +196.4% | -89,3 k € | -144.5% | 200,6 k € | +4.4% | 192,1 k € | +48.7% | 129,2 k € | -5.6% | 136,8 k € | +21.6% | 112,5 k € | -12.3% | 128,3 k € | +4.9% | 122,2 k € | -17.7% | 148,4 k € | -11.4% | 167,5 k € | +0.5% | 166,7 k € | +12.7% | 147,9 k € | +12.2% | 131,8 k € | -13.5% | 152,4 k € | -4.5% | 159,6 k € | +16.8% | 136,7 k € | +35.0% | 101,3 k € | |
| EBITDA | -316,4 € | -100.5% | 69,6 k € | +154.7% | -127,1 k € | -169.7% | 182,3 k € | -2.9% | 187,9 k € | +49.3% | 125,9 k € | -5.8% | 133,6 k € | +21.4% | 110,0 k € | +14.6% | 96,1 k € | -19.6% | 119,5 k € | -18.5% | 146,6 k € | -10.8% | 164,4 k € | +0.4% | 163,8 k € | +12.7% | 145,4 k € | +13.3% | 128,2 k € | -11.5% | 144,9 k € | -7.6% | 156,8 k € | +25.4% | 125,0 k € | +17.2% | 106,7 k € | |
| Operating profit | -24,0 k € | -165.2% | 36,7 k € | +122.9% | -160,5 k € | -207.0% | 150,0 k € | -4.5% | 157,1 k € | +58.4% | 99,2 k € | -13.6% | 114,7 k € | +26.0% | 91,1 k € | +26.6% | 72,0 k € | -24.6% | 95,4 k € | -21.6% | 121,7 k € | -14.1% | 141,6 k € | -4.1% | 147,6 k € | +16.3% | 126,9 k € | +21.4% | 104,6 k € | +4.4% | 100,2 k € | -5.2% | 105,7 k € | +15.6% | 91,4 k € | +27.3% | 71,8 k € | |
| Profit/loss | -26,5 k € | -174.3% | 35,6 k € | +121.8% | -163,2 k € | -258.7% | 102,8 k € | -3.2% | 106,3 k € | +44.7% | 73,5 k € | -9.3% | 81,0 k € | +41.9% | 57,1 k € | +19.6% | 47,7 k € | -26.4% | 64,8 k € | -15.0% | 76,3 k € | -26.0% | 103,1 k € | -2.4% | 105,7 k € | +18.5% | 89,2 k € | +15.3% | 77,3 k € | +16.5% | 66,3 k € | +3.4% | 64,2 k € | +6.6% | 60,2 k € | +45.3% | 41,5 k € | |
| Equity | 640,4 k € | -3.9% | 666,7 k € | +5.6% | 631,1 k € | -26.0% | 852,4 k € | +7.0% | 796,6 k € | +5.5% | 755,1 k € | -0.2% | 756,7 k € | +12.0% | 675,8 k € | +9.2% | 618,7 k € | -3.5% | 641,0 k € | +11.3% | 576,1 k € | +15.3% | 499,8 k € | +16.3% | 429,6 k € | +0.2% | 429,0 k € | -12.4% | 489,8 k € | +18.7% | 412,5 k € | +19.2% | 346,2 k € | +22.8% | 282,0 k € | +27.2% | 221,8 k € | |
| Total assets | 718,9 k € | -2.9% | 740,1 k € | -3.0% | 763,1 k € | -18.7% | 939,1 k € | +6.1% | 885,2 k € | +5.2% | 841,2 k € | +10.3% | 762,9 k € | +6.9% | 713,8 k € | -1.3% | 723,0 k € | +3.9% | 695,9 k € | +13.0% | 616,1 k € | +1.1% | 609,2 k € | -8.3% | 664,2 k € | +6.9% | 621,3 k € | +4.1% | 596,5 k € | +1.4% | 588,5 k € | +2.9% | 571,8 k € | +10.2% | 518,6 k € | +8.5% | 478,0 k € | |
| Cash | 58,2 k € | -39.4% | 96,1 k € | -54.0% | 209,0 k € | -48.1% | 402,4 k € | +17.2% | 343,4 k € | +53.2% | 224,2 k € | +40.3% | 159,8 k € | -27.0% | 219,0 k € | -8.7% | 239,8 k € | -34.9% | 368,2 k € | +197.4% | 123,8 k € | +428.3% | 23,4 k € | +3.2% | 22,7 k € | -8.0% | 24,7 k € | +7.7% | 22,9 k € | -72.6% | 83,7 k € | +372.1% | 17,7 k € | -19.8% | 22,1 k € | +97.8% | 11,2 k € | |
| Debts | 78,5 k € | +7.0% | 73,4 k € | -44.4% | 132,0 k € | +52.4% | 86,6 k € | -2.3% | 88,6 k € | +2.9% | 86,1 k € | +1289.0% | 6,2 k € | -83.7% | 38,0 k € | -63.6% | 104,3 k € | +90.0% | 54,9 k € | +37.4% | 39,9 k € | -63.5% | 109,4 k € | -53.4% | 234,6 k € | +22.4% | 191,6 k € | +79.6% | 106,7 k € | -39.4% | 176,0 k € | -22.0% | 225,6 k € | -4.7% | 236,7 k € | -7.6% | 256,2 k € | |
Source: Belgian Official Gazette
Private company with limited liability · Rumst · incorporated on 02/03/1998
Private company with limited liability loss-making in the latest fiscal year. Cash position declining (-39.4%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DOKTER PHILIPPE COLANS is a Private company with limited liability incorporated in 1998. Its main activity is: General medical practice activities. Its registered office is in Rumst.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.